Pharma and Biotech
Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
30-Sep-25 | 79.70 | (4.10) | 26.63p | 0.9 | n/a | n/a | n/a | 0.0% |
30-Sep-26 | 83.70 | 11.30 | 1.10p | 22.5 | n/a | -96% | n/a | 0.0% |
Copyright © 2025 FactSet Research Systems Inc. All rights reserved.
Current | 1 week ago | 1 month ago | 3 months ago | 6 months ago | 1 year ago | |
---|---|---|---|---|---|---|
Revenue (£m) | ||||||
30-Sep-2025 | 80 | n/a | n/a | 83 | 143 | 190 |
30-Sep-2026 | 84 | n/a | n/a | 86 | 150 | 213 |
30-Sep-2027 | n/a | n/a | n/a | 94 | n/a | n/a |
Earnings | ||||||
30-Sep-2025 | 26.63p | n/a | n/a | 13.71p | 0.20p | 1.00p |
30-Sep-2026 | 1.10p | n/a | n/a | 1.20p | 0.40p | 1.70p |
30-Sep-2027 | n/a | n/a | n/a | 1.60p | n/a | n/a |
Dividend | ||||||
30-Sep-2025 | n/a | n/a | n/a | n/a | n/a | n/a |
30-Sep-2026 | n/a | n/a | n/a | n/a | n/a | n/a |
30-Sep-2027 | n/a | n/a | n/a | n/a | n/a | n/a |
Recommendations | ||||||
Strong Buy | 0 | 0 | 0 | 1 | 0 | 0 |
Buy | 0 | 0 | 0 | 1 | 1 | 1 |
Neutral | 0 | 0 | 0 | 0 | 0 | 1 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Brokers | 0 | 0 | 0 | 2 | 1 | 2 |
Average Rec | n/a | n/a | n/a | 8.75 | 7.50 | 6.25 |
Find out about IFRS and how this affects the financial infomation for all UK companies.
Currency | UK Pounds |
Share Price | 24.70p |
Change Today | 0.000p |
% Change | 0.00 % |
52 Week High | 42.00 |
52 Week Low | 17.70 |
Volume | 54,509 |
Shares Issued | 742.42m |
Market Cap | £183.38m |
Beta | 0.01 |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income | ![]() |
---|
Growth |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
No dividends found |
Time | Volume / Share Price |
15:42 | 4 @ 24.60p |
14:44 | 90 @ 24.60p |
13:32 | 0 @ 24.60p |
13:32 | 0 @ 24.80p |
13:32 | 411 @ 24.60p |
CFO | Septima Maguire |
CEO | Trond Williksen |
Chair | Tripp Lane |
You are here: research